Amalgamated Bank Precigen, Inc. Transaction History

Amalgamated Bank

$12.1 Billion
Q3 2024

A detailed history of Amalgamated Bank transactions in Precigen, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 4,621 shares of PGEN stock, worth $3,974. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,621

Previous 4,621 -0.0%

Holding current value

$3,974

Previous $7,000 42.86%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.27 - $1.75 $1,673 - $2,306	1,318 Added 39.9%	4,621 $7,000
Q1 2024 Apr 23, 2024	SELL	$1.21 - $1.75 $8,748 - $12,652	-7,230 Reduced 68.64%	3,303 $5,000
Q4 2023 Feb 06, 2024	SELL	$0.89 - $1.41 $874 - $1,386	-983 Reduced 8.54%	10,533 $14,000
Q2 2023 Aug 11, 2023	SELL	$0.96 - $1.4 $3,440 - $5,017	-3,584 Reduced 23.74%	11,516 $13,000
Q1 2023 May 02, 2023	SELL	$0.88 - $2.19 $252 - $628	-287 Reduced 1.87%	15,100 $16,000
Q3 2022 Nov 09, 2022	BUY	$1.41 - $2.79 $304 - $602	216 Added 1.42%	15,387 $33,000
Q2 2022 Aug 15, 2022	BUY	$1.15 - $2.53 $223 - $490	194 Added 1.3%	15,171 $20,000
Q1 2022 Jun 30, 2022	SELL	$1.91 - $3.98 $2,301 - $4,795	-1,205 Reduced 7.45%	14,977 $32,000
Q4 2021 Feb 15, 2022	SELL	$3.53 - $5.5 $1,613 - $2,513	-457 Reduced 2.75%	16,182 $60,000
Q3 2021 Oct 29, 2021	SELL	$4.99 - $6.55 $3,438 - $4,512	-689 Reduced 3.98%	16,639 $83,000
Q2 2021 Aug 16, 2021	BUY	$6.24 - $8.22 $108,126 - $142,436	17,328 New	17,328 $113,000
Q2 2020 Aug 10, 2020	SELL	$2.16 - $5.46 $25,313 - $63,985	-11,719 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$1.46 - $7.19 $17,109 - $84,259	11,719 New	11,719 $40,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

159M

Call Options Held

232K

Put Options Held

69K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $179M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.

Account

Amalgamated Bank Precigen, Inc. Transaction History